{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-113.17",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 § 113.17 - Medical Cannabis Marketing and Advertising",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 § 113.17 - Medical Cannabis Marketing and Advertising\n\nState Regulations\n(a) General Requirements. (1)\n\nMedical cannabis marketing, advertising, and advertisements shall only include true and accurate statements relating to\neffectiveness, side effects, consequences or contraindications. It shall\npresent a fair balance between information relating to effectiveness, side\neffects, consequences, and contraindications in that the information relating\nto effectiveness may not be presented in greater scope, depth, or detail than\nis the information relating to side effects, consequences and\ncontraindications, taking into account all implementing factors such as\ntypography, layout, contrast, headlines, paragraphing, white space, and any\nother techniques apt to achieve emphasis. (2)\nA registered organization may engage in\nreasonable advertising practices that are not otherwise prohibited in this\n\nPart, provided the marketing, advertising, and any advertisement do not\njeopardize public health or safety, promote youth use, or be attractive to\nindividuals under 21 as set forth in section\n113.12\n(j)(1)\nof\nthis Part. (3)\nA registered\norganization shall ensure that an official translation of a foreign language\nadvertisement is accurate. (4)\n\nAny\nadvertisement of medical cannabis or medical cannabis products shall, unless\notherwise approved by the office, include a required warning statement that\ndepends on that advertisement's form: (i) If\nthe advertisement contains only visual elements, or a combination of audio and\nvisual elements, then the following statements shall be included in a\nconspicuous manner on the face of the advertisement or be read aloud clearly at\nthe same volume and pace and in the same language as the rest of the\nadvertisement: \"For use only by certified registered patients. Keep out of\nreach of children and pets. In case of accidental ingestion or overconsumption, contact your Poison Center at 1-800-222-1222 or call 9-1-1. Please consume\nresponsibly.\"; (ii)\n\nIf the\nadvertisement contains only auditory elements, then the following statements\nshall be clearly read aloud at the same volume and pace and in the same\nlanguage as the rest of the advertisement: \"For use only by certified patients. Keep out of reach of children and pets. In case of accidental ingestion or\noverconsumption, contact your Healthcare Provider or Poison Center.\"; and\n(iii)\nany other statements or\nwarnings as directed by the board. (5)\n\nStatements or warnings in print or\ndigital advertisements pursuant to this section shall be displayed as follows: (i) in the same language as the\nadvertisement; (ii)\nin Times New\n\nRoman, Calibri, Arial, or Helvetica; (iii)\nin text no smaller than size six (6)\nfont; (iv)\nbolded; (v) be legible, unobscured, and visible to\nthe consumer; and\n(vi)\nin a bright\nyellow text box so as to stand out from the surrounding advertisement. The use\nof a bright yellow color for the warning shall not render the advertisement\nattractive to individuals under 21 as prohibited by section\n113.12\nof this Part. If the\nsurrounding advertisement is yellow in color, the text box shall be offset with\na distinctive border so as to differentiate it from the surrounding\nadvertisement. (6)\nA\nregistered organization shall only advertise medical cannabis products, cannabis paraphernalia, or goods or services related to medical cannabis or\ncannabis products by means of television, radio, print, internet, mobile\napplications, social media, other electronic communication, or other print\npublication if the registered organization has reliable evidence that at least\n90%, unless otherwise determined by the office, of the audience for the\nadvertisement is reasonably expected to be 21 years of age or older. The burden\nof proof of the audience composition lies with the registered\norganization. (7)\nA registered\norganization shall maintain records and documentation to establish that its\nadvertising and marketing meet the requirements of this section. (8)\nA registered organization may sponsor a\ncharitable, sports, or similar event provided however, a registered\norganization shall not engage in advertising at, or in connection with, such an\nevent: (i) any advertisements consist only, at\na maximum, of the registered organization's logo and the following text: (a) the registered organization's name, entity name, or doing business as name or; (b) the registered organization's website\nURL, email address, and phone number; (c) if the registered organization is\nauthorized to conduct retail sales, the registered organization retail\ndispensary's location; and\n(d) the\nnature of the business; and\n(e) the\nlocation(s) of the registered organization's dispensing site(s); and\n(ii)\nthat the advertising and\nmarketing at eligible events shall comply with this Part. (9)\nA registered organization shall limit the\napparel displaying its brand and trademark used in connection with the sale of\napparel displaying its brand to only adult sizes. Such apparel shall only be\nsold by the registered organization within its registered premises. (10)\nA registered organization shall\naccurately and legibly include its name and registration number on in all\nadvertisements, unless the form of the advertisement has exempted from this\nrequirement by the office. (11)\nA\nregistered organization who advertises via a website or digital application\nshall have a mechanism designed to keep those under the age of twenty-one (21)\nfrom visiting the website or digital application, notwithstanding a certified\npatient or designated caregiver who is at least eighteen years of age and\nvisiting the website to purchase medical cannabis. (12)\nA registered organization who has\nentered into an intellectual property licensing agreement, marketing or\nadvertising agreement or any other agreement in which a registered organization\nauthorizes the use of its intellectual property, or allows a third party to\nmarket or advertise on its behalf, the registered organization is responsible\nto ensure that such agreement, intellectual property use, marketing or\nadvertising shall comply with this Part. (13)\nA registered organization shall comply\nwith requests from the Office to change any marketing and advertisements that\nare determined to be false, misleading, or deemed necessary to protect public\nhealth and safety. (14)\nA\nregistered organization shall comply with any additional requirements as set\nforth by the Office. (b) No marketing, advertising, or advertisement of medical cannabis products shall: (1)\ndepict medical cannabis not otherwise\npermitted by section\n113.12\nof this Part or\nparaphernalia; (2)\nuse or display\nimages designed in any manner to be attractive to individuals under twenty-one\n(21); (3)\nuse audio that may be\nattractive to individuals under twenty-one (21), including but not limited to\nusing children's voices or cartoon voices; (4)\nbe on or in the form of a\nbillboard; (5)\nuse or display\ncolloquial references to marijuana and cannabis or depictions, of cannabis, cannabis products, medical cannabis products, paraphernalia, or the imagery or\naction of smoking or vaping, including but not limited to \"stoner\", \"chronic\", \"weed\", \"pot\", or \"sticky buds\" unless such reference is used in the registered\norganization's names, entity name, doing business as name, or logo; (6)\nassert that medical cannabis or medical\ncannabis products are safe or effective because they are regulated by the Board\nor Office; (7)\npermit the use of\ntheir trademarks, brands, names, locations, or other distinguishing\ncharacteristics for third-party use on advertising in a manner that does not\ncomply with this Part or any other statute, rule or regulation; (8)\ncontain any statement, design, representation, picture or illustration related to the safety or efficacy of\nmedical cannabis, unless supported by substantial evidence or substantial\nclinical data which shall be referenced in the advertisement and provided to\nthe Office upon request; (9)\ncontain favorable information or opinions about a medical cannabis product\npreviously regarded as valid but which have been rendered invalid by contrary\nand more credible recent information; (10)\nuse a quote or paraphrase out of context\nor without citing conflicting information from the same source, to convey a\nfalse or misleading idea; (11)\ncontain favorable information or conclusions from a study that is inadequate in\ndesign, scope, or conduct to furnish significant support for such information\nor conclusions; (12)\nuse data\nfavorable to a medical cannabis product derived from patients treated with a\ndifferent product or form; (13)\ndisparage cannabis or medical cannabis products from another registered\norganization or licensed entity; (14)\nfail to provide adequate emphasis for\nthe fact that two (2) or more facing pages are part of the same advertisement\nwhen only one (1) page contains information relating to side effects, consequences and contraindications; (15)\ndisseminate any advertisement if the\nregistered organization has received information that has not been widely\npublicized in medical literature that the use of any medical cannabis product\nmay cause fatalities or serious damage to a patient; (16)\ncorrect false or misleading information\nin any part of the advertisement by including a true statement in another\ndistinct part of the advertisement; (17)\nuse the term \"organic\"; (18)\ncontain any statement, design, representation, picture or illustration that encourages or represents the use\nof medical cannabis that does not comport with Article 3 of the Cannabis Law or\npromotes overconsumption; (19)\nfalsely portray medical cannabis or cannabis products as being in compliance\nwith Article 4 and Article 5 of the Cannabis Law; (20)\ncontain any statement that indicates or\nimplies that the product or entity in the advertisement has been approved or\nendorsed by any New York State employee or any person or entity associated with\n\nNew York State provided that this shall not preclude a factual statement that\nan entity is a registered organization; (21)\nencourage the transportation of medical\ncannabis across state lines or otherwise encourage illegal activity; (22)\ndepict a child or other person under the\nage of twenty-one (21) or reasonably appearing to be under the age of\ntwenty-one (21). Talent portrayed in medical cannabis advertising should be a\nminimum of twenty-five years old, substantiated by proper identification, and\nan actual certified patient, designated caregiver or health care practitioner\nand not a model or actor; (23)\ncontain any obscene or indecent statement, design, or representation, picture, or illustration; (24)\nbe within or\nbe readily observed within 500 feet of an elementary or secondary school\ngrounds as defined in Education Law, recreation center or facility, childcare\ncenter, playground, public park, or library; (25)\nbe on or through handbills that are\npassed out in public areas including but not limited to parking lots and\npublicly owned property; (26)\nutilize unsolicited pop-up or banner advertising on the internet other than on\nage-restricted websites for people twenty-one (21) and over who consent to view\ncannabis-related material, notwithstanding a certified patient or designated\ncaregiver who is at least eighteen years of age and visiting the website to\npurchase medical cannabis; (27)\ncooperate, directly or indirectly, in any advertising if such advertising has\nthe purpose or effect of steering or influencing patient or caregiver choice\nwith regard to the selection of a practitioner. Nothing contained within this\nsection prevents a registered organization from educating practitioners about\nmedical cannabis products offered by the registered organization; (28)\nuse a commercial mascot; or\n(29)\nviolate any additional prohibitions\ndetermined by the Board or Office. (c) A registered organization shall not use\nfalse or misleading information in any part of the advertisement. An\nadvertisement is false, lacking in fair balance, or otherwise misleading if it: (1)\ncontains a representation or suggestion\nthat one medical cannabis product, brand, or form is better, more effective, useful in a broader range of conditions or patients or safer than other drugs\nor treatments including other medical cannabis products or forms, unless such a\nclaim has been demonstrated by substantial scientific evidence or clinical\nexperience; (2)\ncontains favorable\ninformation or opinions about a medical cannabis product previously regarded as\nvalid but which have been rendered invalid by contrary and more credible recent\ninformation; (3)\nuses a quote or\nparaphrase out of context or without citing conflicting information from the\nsame source, to convey a false or misleading idea; (4)\nuses data favorable to a medical cannabis\nproduct derived from patients treated with a different product or\nform; (5)\ncontains favorable\ninformation or conclusions from a study that is inadequate in design, scope, or\nconduct to furnish significant support for such information or conclusions; or\n(6)\nfails to provide adequate\nemphasis for the fact that two (2) or more facing pages are part of the same\nadvertisement when only one (1) page contains information relating to side\neffects, consequences and contraindications. (d) Outdoor Signs. (1)\nA registered organization may advertise\noutdoors using signs provided such signs: (i) are for the purpose of alerting individuals to the location of a dispensing\nsite; (ii)\nare limited to the\nfollowing information: (a) business or trade\nname, (b) business location, and\n(c) the nature of the business; (iii)\nare affixed to\na building or permanent structure; (iv)\nare not on vehicles except where a\nregistered organization name and address are required on a vehicle to comply\nwith any other state or local laws or regulations; and\n(v) do not total more than two in number per\ndispensing site. (2)\n\nMarketing or advertising is prohibited on signs and placards, regardless of\ntheir size or purpose, in arenas, stadiums, other sport venues, shopping malls\nunless alerting individuals to the location of a dispensing site located within\nthat mall, fairs that receive state allocations, and video game arcades, regardless of whether any of the foregoing are open air or enclosed, but this\ndoes not include any such sign or placard located at an adult only facility or\nas further set out by the office in guidance. (3)\nA registered organization shall remove an\noutdoor sign if the office determines the outdoor sign violates the provisions\nof Cannabis Law and this Part or if the registered organization fails to\nprovide records to the office upon request that establishes the outdoor signage\nmeets the requirements of Cannabis Law and this Part. (4)\n\nOutdoor dispensing site sign must comply\nwith any additional requirements as set out by the office. (e) Marketing and Advertising Violations and\n\nPenalties. (1)\nA registered organization shall\nimmediately remove or discontinue advertising or marketing if the Board\ndetermines the advertising, marketing, or outdoor signage violates the\nprovisions of the Cannabis Law and this Part or if the registered organization\nfails to provide records to the Office upon request that establishes the\nadvertising and marketing meets the requirements of the Cannabis Law and this\n\nPart. (2)\n\nIn the event a\nthird-party has used a registered organization's trademarks, brands, names, locations, or other distinguishing characteristics in an advertisement that\ndoes not comply with this Part or any other statute, rule or regulation, the\nregistered organization must immediately notify the office and issue a\ncease-and-desist notification to the third-party. (3)\n\nThe Office may take any action against\nany registered organization who fails to comply with this Part, including but\nnot limited to recommendations to the Board for suspension, cancellation, or\nrevocation of a registration, imposition of any fees or fines, requiring a\nregistered organization to cease by a date determined by the Office the\nnon-compliant marketing and advertising and requiring removal by a date\ndetermined by the Office of any marketing material or advertising still being\npublished or displayed, and any other penalties set forth in Cannabis Law and\nthis Part 113. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\n§\n113.17\n\nAdopted\n\nNew\n\nYork State Register February 22, 2023/Volume XLV, Issue 08, eff. 2/22/2023\n\nAmended\n\nNew\n\nYork State Register March 27, 2024/Volume XLVI, Issue 13, eff. 3/27/2024\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. (a) General Requirements. (1)\n\nMedical cannabis marketing and\nadvertising\nshall only include true and accurate statements relating to effectiveness, side effects, consequences or contraindications, regardless of marketing or\nadvertising\nform. It shall present a fair balance between information relating to effectiveness, side effects, consequences, and contraindications in that the information relating to effectiveness\nmay\nnot be presented in greater scope, depth, or detail than is the information relating to side effects, consequences and contraindications, taking into account all implementing factors such as typography, layout, contrast, headlines, paragraphing, white space, and any other techniques apt to achieve emphasis. (2)\nA\nregistered organization\nmay\nengage in reasonable\nadvertising\npractices that are not otherwise prohibited in this Part, provided the marketing and\nadvertising\ndoes not jeopardize public health or safety, promote youth use, or be\nattractive to individuals under twenty-one\n(21) as set forth in section\n113.12\n(k)(1)\nof this Part. (3)\nA\nregistered organization\nshall ensure that an official translation of a foreign language\nadvertisement\nis accurate. (4)\n\nAny marketing or\nadvertisement\nof medical cannabis or medical cannabis products shall include the following statements, in a conspicuous manner on the face of the marketing material or\nadvertisement\nor be read aloud clearly at the same volume and pace as the rest of the\nadvertisement: (i) \"Keep out of reach of children and pets.\"; (ii)\n\"In case of accidental ingestion or overconsumption, contact the National Poison\n\nControl\n\nCenter hotline 1-800-222-1222 or call 9-1-1.\"; (iii)\n\"Please consume responsibly.\"; and\n(iv)\nany other statements or warnings as directed by the\n\nBoard. (5)\nstatements or warnings in print or digital advertisements pursuant to this section shall be displayed as follows: (i) in the English language; (ii)\nin Times New Roman, Calibri, Arial, or Helvetica; (iii)\nin text no smaller than size six (6) font; (iv)\nbolded; (v) be legible, unobscured, and visible to the consumer; and\n(vi)\nin a bright yellow text box so as to stand out from the surrounding\nadvertisement. The use of a bright yellow color for the warning shall not render the\nadvertisement\nattractive to individuals under twenty-one\n(21) as prohibited by section\n113.12\nof this Part. If the surrounding\nadvertisement\nis yellow in color, the text box shall be offset with a distinctive border so as to differentiate it from the surrounding\nadvertisement. (6)\nA\nregistered organization\nshall only advertise medical cannabis products, cannabis paraphernalia, or goods or services related to medical cannabis or cannabis products by means of television, radio, print, internet, mobile applications, social media, other electronic communication, or print publication if the\nregistered organization\nhas reliable evidence that at least 90%, unless otherwise determined by the\n\nOffice, of the audience for the\nadvertisement\nis reasonably expected to be twenty-one (21) years of age or older. The burden of proof of the audience composition lies with the\nregistered organization. (7)\nA\nregistered organization\nshall maintain records and documentation to establish that its\nadvertising\nand marketing meet the requirements of this section. (8)\nA\nregistered organization\nmay\nsponsor\na charitable, sports, or similar event provided however, a\nregistered organization\nshall not engage in\nadvertising\nat, or in connection with, such an event unless the\nregistered organization\nhas reliable evidence that at least 90%, unless otherwise determined by the\n\nOffice, of the audience at the event and/or viewing\nadvertising\nin connection with the event is reasonably expected to be twenty-one (21) years of age or older. Advertising\nand marketing at eligible events must comply with this Part. (9)\nA\nregistered organization\nshall limit the apparel displaying its brand and trademark used in connection with the sale of apparel displaying its brand to only adult sizes. Such apparel shall only be sold by the\nregistered organization\nwithin its registered premises. (10)\nA\nregistered organization\nshall accurately and legibly include its name and registration number on all\nadvertising\nand marketing for its products. (11)\nA\nregistered organization\nwho advertises via a website or digital application shall have a mechanism designed to keep those under the age of twenty-one (21) from visiting the website or digital application, notwithstanding a\ncertified patient\nor designated caregiver who is at least eighteen years of age and visiting the website to purchase medical cannabis. (12)\nA\nregistered organization\nwho has entered into an intellectual\nproperty\nlicensing agreement, marketing or\nadvertising\nagreement or any other agreement in which a\nregistered organization\nauthorizes the use of its intellectual\nproperty, or allows a third party to market or advertise on its behalf, the\nregistered organization\nis responsible to ensure that such agreement, intellectual\nproperty\nuse, marketing or\nadvertising\nshall comply with this Part. (13)\nA\nregistered organization\nshall comply with requests from the\n\nOffice\nto change any marketing and advertisements that are determined to be false, misleading, or deemed necessary to protect public health and safety. (14)\nA\nregistered organization\nshall comply with any additional requirements as set forth by the\n\nOffice. (b) No marketing or\nadvertising\nof medical cannabis products shall: (1)\ndepict medical cannabis not otherwise permitted by section\n113.12\nof this Part or paraphernalia; (2)\nuse or display images designed in any manner to be\nattractive to individuals under twenty-one\n(21); (3)\nuse audio that\nmay\nbe\nattractive to individuals under twenty-one\n(21), including but not limited to using children's voices or cartoon voices; (4)\nbe on or in the\nform\nof a billboard; (5)\nuse or display colloquial references to marijuana and cannabis or depictions or digital images or icons, whether animated or static, of cannabis, cannabis products, medical cannabis products, paraphernalia, or the imagery or action of smoking or vaping, including but not limited to \"stoner\", \"chronic\", \"weed\", \"pot\", or \"sticky buds\"; (6)\nassert that medical cannabis or medical cannabis products are safe or effective because they are regulated by the\n\nBoard\nor\n\nOffice; (7)\npermit the use of their trademarks, brands, names, locations, or other distinguishing characteristics for third-party use on\nadvertising\nin a manner that does not comply with this Part or any other statute, rule or regulation; (8)\ncontain any statement, design, representation, picture or illustration related to the safety or efficacy of medical cannabis, unless supported by substantial evidence or substantial clinical data which shall be referenced in the\nadvertisement\nand provided to the\n\nOffice\nupon request; (9)\ncontain favorable information or opinions about a\nmedical cannabis product\npreviously regarded as valid but which have been rendered invalid by contrary and more credible recent information; (10)\nuse a quote or paraphrase out of context or without citing conflicting information from the same source, to convey a false or misleading idea; (11)\ncontain favorable information or conclusions from a study that is inadequate in design, scope, or conduct to furnish significant support for such information or conclusions; (12)\nuse data favorable to a\nmedical cannabis product\nderived from patients treated with a different product or\nform; (13)\ndisparage cannabis or medical cannabis products from another\nregistered organization\nor licensed entity; (14)\nfail to provide adequate emphasis for the fact that two (2) or more facing pages are part of the same\nadvertisement\nwhen only one (1) page contains information relating to side effects, consequences and contraindications; (15)\ndisseminate any\nadvertisement\nif the\nregistered organization\nhas received information that has not been widely publicized in medical literature that the use of any\nmedical cannabis product\nmay\ncause fatalities or serious damage to a patient; (16)\ncorrect false or misleading information in any part of the\nadvertisement\nby including a true statement in another distinct part of the\nadvertisement; (17)\nuse the term \"organic\"; (18)\ncontain any statement, design, representation, picture or illustration that encourages or represents the use of medical cannabis that does not comport with Article 3 of the Cannabis\n\nLaw\nor promotes overconsumption; (19)\nfalsely portray medical cannabis or cannabis products as being in compliance with Article 4 and Article 5 of the Cannabis\n\nLaw; (20)\ncontain any statement that indicates or implies that the product or entity in the\nadvertisement\nhas been approved or endorsed by any New York\n\nState\nemployee or any\nperson\nor entity associated with New York\n\nState\nprovided that this shall not preclude a factual statement that an entity is a\nregistered organization; (21)\nencourage the transportation of medical cannabis across\nstate\nlines or otherwise encourage illegal activity; (22)\ncontain any offer of a prize, award or inducement to a\ncertified patient, designated caregiver or\npractitioner\nrelated to the purchase of a\nmedical cannabis product\nor a certification for the use of medical cannabis, provided, however, that, this shall not be construed as to prohibit a\nregistered organization\nfrom offering discounts or a discount\nprogram\nto certified patients and designated caregivers, for the purchase of\nmedical cannabis product; (23)\nadvertise through the marketing of free promotional items including, but not limited to, gifts, giveaways, except for the provision of branded exit packages or items that assist with public safety efforts, such as a lock box or safety storage bag which\nmay\nbe provided by a\nregistered organization\nfor the benefit of certified patients; (24)\nproduce any items for sale or promotional gifts, such as T-shirts or novelty items, bearing a symbol of or references to medical cannabis. This prohibition shall not pertain to\ncannabis paraphernalia\nsold to certified patients or designated caregivers; (25)\ndepict a child or other\nperson\nunder the age of twenty-one (21) or reasonably appearing to be under the age of twenty-one (21). Talent portrayed in medical cannabis\nadvertising\nshould be a minimum of twenty-five years old, substantiated by proper identification, and an actual\ncertified patient, designated caregiver or health care\npractitioner\nand not a model or actor; (26)\ncontain any obscene or indecent statement, design, or representation, picture, or illustration; (27)\nbe within or be readily observed within 500 feet of an elementary or\nsecondary school\ngrounds as defined in Education\n\nLaw, recreation center or facility, childcare center, playground, public park, or library; (28)\nbe on or through handbills that are passed out in public areas including but not limited to parking lots and publicly owned\nproperty; (29)\nutilize unsolicited pop-up or banner\nadvertising\non the internet other than on age-restricted websites for people twenty-one (21) and over who consent to view cannabis-related material, notwithstanding a\ncertified patient\nor designated caregiver who is at least eighteen years of age and visiting the website to purchase medical cannabis; (30)\ncooperate, directly or indirectly, in any\nadvertising\nif such\nadvertising\nhas the purpose or effect of steering or influencing patient or caregiver choice with regard to the selection of a\npractitioner. Nothing contained within this section prevents a\nregistered organization\nfrom educating practitioners about medical cannabis products offered by the\nregistered organization; or\n(31)\nviolate any additional prohibitions determined by the\n\nBoard\nor\n\nOffice. (c) A\nregistered organization\nshall not use false or misleading information in any part of the\nadvertisement. An\nadvertisement\nis false, lacking in fair balance, or otherwise misleading if it: (1)\ncontains a representation or suggestion that one\nmedical cannabis product, brand, or\nform\nis better, more effective, useful in a broader range of conditions or patients or safer than other drugs or treatments including other medical cannabis products or forms, unless such a claim has been demonstrated by substantial scientific evidence or clinical experience; (2)\ncontains favorable information or opinions about a\nmedical cannabis product\npreviously regarded as valid but which have been rendered invalid by contrary and more credible recent information; (3)\nuses a quote or paraphrase out of context or without citing conflicting information from the same source, to convey a false or misleading idea; (4)\nuses data favorable to a\nmedical cannabis product\nderived from patients treated with a different product or\nform; (5)\ncontains favorable information or conclusions from a study that is inadequate in design, scope, or conduct to furnish significant support for such information or conclusions; or\n(6)\nfails to provide adequate emphasis for the fact that two (2) or more facing pages are part of the same\nadvertisement\nwhen only one (1) page contains information relating to side effects, consequences and contraindications. (d) Outdoor Marketing and\n\nAdvertising. (1)\n\nOutdoor dispensing\nsite\nsignage for the purpose of alerting individuals to the location of a medical cannabis dispensing\nsite\nis permitted provided such signs: (i) are limited to the following information\n(a) business or trade name, (b) business location, and\n(c) the nature of the business; (ii)\nare affixed to a building or permanent\nstructure; (iii)\nare not illuminated by neon lights; (iv)\nare not on vehicles owned, leased, or utilized by registered organizations; (v) do not total more than two (2) in number per dispensing\nsite; and\n(vi)\ndo not depict cannabis, cannabis products, or the imagery or action of smoking or vaping. (2)\n\nOutdoor marketing or\nadvertising\nis prohibited on signs and placards in arenas, stadiums, shopping malls, fairs that receive\nstate\nallocations, and video game arcades, whether any of the foregoing are open air or enclosed, but does not include any such sign or placard located at an adult only facility or as further set out by the\n\nOffice\nin guidance. (3)\n\nUse of a commercial mascot is prohibited. (4)\nA\nregistered organization\nshall remove the outdoor signage if the\n\nOffice\ndetermines the outdoor signage violates the provisions of Cannabis\n\nLaw\nand this Part or if the\nregistered organization\nfails to provide records to the\n\nOffice\nupon request that establishes the outdoor signage meets the requirements of Cannabis\n\nLaw\nand this Part. (5)\n\nOutdoor dispensing\nsite\nsignage must comply with any additional requirements as set out by the\n\nOffice. (e) Marketing and\n\nAdvertising\n\nViolations and Penalties. (1)\nA\nregistered organization\nshall immediately remove or discontinue\nadvertising\nor marketing if the\n\nBoard\ndetermines the\nadvertising, marketing, or outdoor signage violates the provisions of the Cannabis\n\nLaw\nand this Part or if the\nregistered organization\nfails to provide records to the\n\nOffice\nupon request that establishes the\nadvertising\nand marketing meets the requirements of the Cannabis\n\nLaw\nand this Part. (2)\n\nIn the event a third-party has used a\nregistered organization\n's trademarks, brands, names, locations, or other distinguishing characteristics in an\nadvertisement\nthat does not comply with this Part or any other statute, rule or regulation, the\nregistered organization\nmust immediately notify the\n\nOffice, issue a cease-and-desist notification to the third-party, and\nmay\npursue appropriate legal action. (3)\n\nThe\n\nOffice\nmay\ntake any action against any\nregistered organization\nwho fails to comply with this Part, including but not limited to recommendations to the\n\nBoard\nfor suspension, cancellation, or revocation of a registration, imposition of any fees or fines, requiring a\nregistered organization\nto cease by a date determined by the\n\nOffice\nthe non-compliant marketing and\nadvertising\nand requiring removal by a date determined by the\n\nOffice\nof any marketing material or\nadvertising\nstill being published or displayed, and any other penalties set forth in Cannabis\n\nLaw\nand this Part 113. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\n§\n113.17\n\nAdopted\n\nNew York\n\nState\n\nRegister February 22, 2023/Volume XLV, Issue 08, eff. 2/22/2023",
  "url_type": "regulation",
  "source_index": 32594
}